Loading...
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
No validated prognostic tool is available for predicting overall survival (OS) of patients with well-differentiated neuroendocrine tumors (WDNETs). This study, conducted in three independent cohorts of patients from five different European countries, aimed to develop and validate a classification pr...
Saved in:
| Published in: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bioscientifica Ltd
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920017/ https://ncbi.nlm.nih.gov/pubmed/29559553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|